Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Rotaru Luciana Teodora, University of Medicine and Pharmacy, Romania.
(2) Cirimbei Ciprian, Bucharest Institute of Oncology, Romania.
Additional Reviewers:
(1) Enrico Pessina, ASL CN2, Italy.
(2) Long Niu, Dalian Medical University, China.
(3) Sina Dindarian, Urmia University of Medical Sciences, Iran
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.25/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Rotaru Luciana Teodora, Romania) | File 1 | NA
Stage 2 | Peer review report_2 (Cirimbei Ciprian, Romania) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA